Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)

✍ Scribed by Brigitte Mlineritsch; Christoph Tausch; Christian Singer; Gero Luschin-Ebengreuth; Raimund Jakesz; Ferdinand Ploner; Michael Stierer; Elisabeth Melbinger; Christian Menzel; Andrea Urbania; Michael Fridrik; Günther Steger; Peter Wohlmuth; Michael Gnant; Richard Greil; on behalf of the Austrian Breast, Colorectal Cancer Study Group (ABCSG)

• Publisher: Springer US
• Year: 2007
• Tongue: English
• Weight: 267 KB
• Volume: 112
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-007-9843-x